For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

The most important risk factor for esophageal adenocarcinoma is Barret’s esophagus (BE), a pre-malignant condition in which the normal squamous lining in the esophagus has been replaced by a columnar epithelium containing intestinal metaplasia (IM) as a result of chronic gastroesophageal reflux disease. Nadine Phoa seeks to optimise endoscopic management strategies for patients with Barret’s esophagus containing dysplasia. To that end, she focuses on patients with dysplasia throughout the entire spectrum: from early cancers high-grade dysplasia to low-grade dysplasia patients.

Event details of Endoscopic treatment of Barret’s esophagus
Date 30 October 2014
Time 14:00 -15:00
Location Agnietenkapel

K.Y.N. Phoa, Endoscopic Management of Barrett’s Esophagus with Dysplasia.


Prof. J.J.G.H.M. Bergman
Prof. J.G.P. Tijssen


Dr R.E. Pouw
Dr R.C. Mallant-Hent (Flevoziekenhuis)


Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam


This event is open to the public.